Nevro Corp (NVRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 408,518 | 425,174 | 406,365 | 386,905 | 362,048 |
| Cost of Goods | 138,990 | 135,114 | 129,998 | 120,863 | 112,146 |
| Gross Profit | 269,528 | 290,060 | 276,367 | 266,042 | 249,902 |
| Operating Expenses | 396,747 | 389,482 | 271,201 | 377,839 | 312,900 |
| Operating Income | -126,229 | -99,308 | 6,164 | -110,934 | -62,852 |
| Interest Expense | 26,887 | 8,014 | 6,432 | 19,749 | 21,806 |
| Other Income | 40,770 | 9,463 | 4,532 | -143 | 2,461 |
| Pre-tax Income | -112,346 | -97,859 | 4,264 | -130,826 | -82,197 |
| Income Tax | 1,093 | -5,646 | 1,263 | 534 | 868 |
| Net Income Continuous | -113,439 | -92,213 | 3,001 | -131,360 | -83,065 |
| Net Income | $-113,439 | $-92,213 | $3,001 | $-131,360 | $-83,065 |
| EPS Basic Total Ops | -3.06 | -2.56 | 0.08 | -3.77 | -2.47 |
| EPS Basic Continuous Ops | -3.06 | -2.56 | 0.09 | -3.77 | -2.47 |
| EPS Diluted Total Ops | -3.06 | -2.56 | 0.08 | -3.77 | -2.47 |
| EPS Diluted Continuous Ops | -3.06 | -2.56 | 0.08 | -3.77 | -2.47 |
| EPS Diluted Before Non-Recurring Items | -2.29 | -2.46 | -2.72 | -3.20 | -2.47 |
| EBITDA(a) | $-73,938 | $-90,502 | $18,112 | $-87,483 | $-39,400 |